Sage Journals: Discover world-class research

Retricted access

Research article

First published 1999-10

A Review of Metabolic and Cardiovascular Effects of Oral Antidiabetic Agents: Beyond Glucose-Level Lowering

Henry Ginsberg, Jorge Plutzky, Burton E. Sobel

European Journal of Preventive Cardiology

Retricted access

Research article

First published 2012-06

Cardiovascular Disease and Oral Agent Glucose-Lowering Therapies in the Management of Type 2 Diabetes

Philip Home

Diabetes Technology & Therapeutics

Open access

Research article

First published 2013-7

Cardiovascular outcome trials in type 2 diabetes and the sulphonylurea controversy: Rationale for the active-comparator CAROLINA trial

Julio Rosenstock, Nikolaus Marx, Steven E Kahn [...]

Diabetes & Vascular Disease Research

Retricted access

Research article

First published 2018-9

Combined use of polypill components in patients with type 2 diabetes mellitus

Vivi E Janssen, Frank L Visseren, Anthonius de Boer [...]

European Journal of Preventive Cardiology

Retricted access

Review article

First published 2015-5

Empagliflozin,an SGLT2 Inhibitor for the Treatment of Type 2 Diabetes Mellitus

John R. White

Annals of Pharmacotherapy

Free access

Research article

First published 2013-5

Satisfaction with glucose-lowering treatment and well-being in patients with type 2 diabetes and myocardial infarction: A DIGAMI2 QoL sub-study

Laura Venskutonyte, Kerstin Brismar, Tina Rydén-Bergsten [...]

Diabetes & Vascular Disease Research

Retricted access

Research article

First published 2006-3

The challenge of tackling cardiovascular outcomes

Anthony H Barnett

The British Journal of Diabetes & Vascular Disease

Free access

Review article

First published 2008-3

Effects of Exenatide on Diabetes,Obesity,Cardiovascular Risk Factors,and Hepatic Biomarkers in Patients with Type 2 Diabetes

Loretta L. Nielsen, Ted Okerson, John Holcombe [...]

Journal of Diabetes Science and Technology

Retricted access

Research article

First published 2012-3

Erlotinib appears to produce prolonged remission of insulin-requiring type 2 diabetes associated with metabolic syndrome and chronic kidney disease

Marvin B. Brooks

The British Journal of Diabetes & Vascular Disease

Retricted access

Research article

First published 1957-5

Blood Glutathione in Mild Diabetes Mellitus Before Treatment and During Sulfonylurea-Induced Hypoglycemia. ∗

Holbrooke S. Seltzer

Experimental Biology and Medicine

Search results